1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Concept

subject area of

• Determination and visualization of damage to striatal dopaminergic terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by [18F]-labeled 6-fluoro-L-dopa and positron emission tomography.  Journal Articles
• Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice  Journal Articles
• Pain Perception in Acute Model Mice of Parkinson's Disease Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)  Journal Articles
• Protection Against MPTP Treatment by an Analog of Pro-Leu-Gly-NH2 (PLG, MIF-1)  Journal Articles
• Therapeutic potential of anti-IL-6 therapies for granulocytic airway inflammation in asthma  Journal Articles